AVITA Medical Limited Form 6-K Summary
Business Context and Reporting Period
AVITA Medical Limited, a foreign private issuer filing annual reports on Form 20-F, furnished this Form 6-K on November 27, 2019. The filing reports the company’s November 18, 2019 Australian Securities Exchange announcement regarding the appointment of David McIntyre as Chief Financial Officer.
Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material Changes Versus Prior Period
The principal disclosed corporate change is the naming of David McIntyre as Chief Financial Officer. The filing text does not provide further details regarding his start date, prior executive, compensation, or transition arrangements.
Guidance, Outlook, Risks, and Unusual Items
No financial guidance, operating outlook, risk updates, contingencies, or unusual financial items are disclosed in the provided filing text.
Investor Verification Items
- Verify the full terms and effective date of David McIntyre’s appointment in the referenced Exhibit 99.1 press release.
- Confirm whether the appointment involved a replacement, interim arrangement, or other executive transition.
- Review subsequent filings for any financial, liquidity, or strategic disclosures not included in this Form 6-K.